Aquestive Therapeutics, Inc. (AQST)
6.21
-0.11
(-1.74%)
USD |
NASDAQ |
Dec 12, 16:00
6.23
+0.02
(+0.32%)
After-Hours: 20:00
Aquestive Therapeutics Shareholders Equity (Quarterly): -4.109M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| TransCode Therapeutics, Inc. | 1.426M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 163.56M |
| Total Liabilities (Quarterly) | 167.67M |
| Debt to Equity Ratio | -31.36 |
| Current Ratio | 5.931 |
| Net Debt Paydown Yield | -0.35% |